NCT01034540View on ClinicalTrials.gov

Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

February 28, 2011

Conditions
Hypertriglyceridemia
Interventions
DRUG

POM3

4 g/day

DRUG

Placebo

matching placebo capsule, 4 g/day

Trial Locations (1)

60101

Provident Clinical Research (now Biofortis), Addison

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Provident Clinical Research

OTHER